|   Diethyl 1-benzyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate structure | Common Name | Diethyl 1-benzyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate | ||
|---|---|---|---|---|
| CAS Number | 120533-76-8 | Molecular Weight | 391.46 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H25NO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Use of Diethyl 1-benzyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylateBML-278 is a SIRT1 activator (EC150: 1 μM). BML-278 increases H3K9 methylation and inhibits H3K9 acetylation in both the paternal and maternal pronucleus. BML-278 improves early embryonic development. BML-278 arrests the cell cycle at the G1/S phase, and reduces senescence in primary human mesenchymal cells. BML-278 reduces tubulin acetylation in U937 cells. BML-278 also increases mitochondrial density in murine C2C12 myoblasts[1][2]. | 
| Name | diethyl 1-benzyl-1,4-dihydro-4-phenylpyridine-3,5-dicarboxylate | 
|---|---|
| Synonym | More Synonyms | 
| Description | BML-278 is a SIRT1 activator (EC150: 1 μM). BML-278 increases H3K9 methylation and inhibits H3K9 acetylation in both the paternal and maternal pronucleus. BML-278 improves early embryonic development. BML-278 arrests the cell cycle at the G1/S phase, and reduces senescence in primary human mesenchymal cells. BML-278 reduces tubulin acetylation in U937 cells. BML-278 also increases mitochondrial density in murine C2C12 myoblasts[1][2]. | 
|---|---|
| Related Catalog | |
| Target | SIRT1[1]. | 
| References | 
| Molecular Formula | C24H25NO4 | 
|---|---|
| Molecular Weight | 391.46 | 
| Exact Mass | 391.17800 | 
| PSA | 55.84000 | 
| LogP | 4.11790 | 
| Precursor 0 | |
|---|---|
| DownStream 1 | |
| .diethyl 1-benzyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate |